These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 20554441)

  • 1. Biochemical network-based drug-target prediction.
    Klipp E; Wade RC; Kummer U
    Curr Opin Biotechnol; 2010 Aug; 21(4):511-6. PubMed ID: 20554441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systems biology analysis of protein-drug interactions.
    Colinge J; Rix U; Bennett KL; Superti-Furga G
    Proteomics Clin Appl; 2012 Jan; 6(1-2):102-16. PubMed ID: 22213655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prediction of potential drug targets based on simple sequence properties.
    Li Q; Lai L
    BMC Bioinformatics; 2007 Sep; 8():353. PubMed ID: 17883836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional pathway pharmacology: chemical tools, pathway knowledge and mechanistic model-based interpretation of experimental data.
    Hendriks BS
    Curr Opin Chem Biol; 2010 Aug; 14(4):489-97. PubMed ID: 20609614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Large-scale prediction of drug-target interactions using protein sequences and drug topological structures.
    Cao DS; Liu S; Xu QS; Lu HM; Huang JH; Hu QN; Liang YZ
    Anal Chim Acta; 2012 Nov; 752():1-10. PubMed ID: 23101647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Signal transduction networks: topology, response and biochemical processes.
    Soyer OS; Salathé M; Bonhoeffer S
    J Theor Biol; 2006 Jan; 238(2):416-25. PubMed ID: 16045939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Network systems biology for drug discovery.
    Arrell DK; Terzic A
    Clin Pharmacol Ther; 2010 Jul; 88(1):120-5. PubMed ID: 20520604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug effects viewed from a signal transduction network perspective.
    Fliri AF; Loging WT; Volkmann RA
    J Med Chem; 2009 Dec; 52(24):8038-46. PubMed ID: 19891439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Druggability assessment of protein-protein interfaces.
    Wanner J; Fry DC; Peng Z; Roberts J
    Future Med Chem; 2011 Dec; 3(16):2021-38. PubMed ID: 22098351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Developmental engineering: a new paradigm for the design and manufacturing of cell-based products. Part II: from genes to networks: tissue engineering from the viewpoint of systems biology and network science.
    Lenas P; Moos M; Luyten FP
    Tissue Eng Part B Rev; 2009 Dec; 15(4):395-422. PubMed ID: 19589040
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DrugBank: a comprehensive resource for in silico drug discovery and exploration.
    Wishart DS; Knox C; Guo AC; Shrivastava S; Hassanali M; Stothard P; Chang Z; Woolsey J
    Nucleic Acids Res; 2006 Jan; 34(Database issue):D668-72. PubMed ID: 16381955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predict potential drug targets from the ion channel proteins based on SVM.
    Huang C; Zhang R; Chen Z; Jiang Y; Shang Z; Sun P; Zhang X; Li X
    J Theor Biol; 2010 Feb; 262(4):750-6. PubMed ID: 19903486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure-based maximal affinity model predicts small-molecule druggability.
    Cheng AC; Coleman RG; Smyth KT; Cao Q; Soulard P; Caffrey DR; Salzberg AC; Huang ES
    Nat Biotechnol; 2007 Jan; 25(1):71-5. PubMed ID: 17211405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Understanding and predicting druggability. A high-throughput method for detection of drug binding sites.
    Schmidtke P; Barril X
    J Med Chem; 2010 Aug; 53(15):5858-67. PubMed ID: 20684613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of potential targets in biological signalling systems through network perturbation analysis.
    Azuaje F; Devaux Y; Wagner DR
    Biosystems; 2010 Apr; 100(1):55-64. PubMed ID: 20079399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug target identification in sphingolipid metabolism by computational systems biology tools: metabolic control analysis and metabolic pathway analysis.
    Ozbayraktar FB; Ulgen KO
    J Biomed Inform; 2010 Aug; 43(4):537-49. PubMed ID: 20348024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular modeling of hydration in drug design.
    Mancera RL
    Curr Opin Drug Discov Devel; 2007 May; 10(3):275-80. PubMed ID: 17554853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Computational approaches to modeling drug transporters.
    Chang C; Swaan PW
    Eur J Pharm Sci; 2006 Apr; 27(5):411-24. PubMed ID: 16274971
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Network biology as a new approach to drug discovery.
    Lowe JA; Jones P; Wilson DM
    Curr Opin Drug Discov Devel; 2010 Sep; 13(5):524-6. PubMed ID: 20812143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A large-scale computational approach to drug repositioning.
    Li YY; An J; Jones SJ
    Genome Inform; 2006; 17(2):239-47. PubMed ID: 17503396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.